{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:27:50Z","timestamp":1795091270422,"version":"4.10.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>To assess the contribution of rare coding germline genetic variants to prostate cancer risk and severity, we perform here a meta-analysis of 37,184 prostate cancer cases and 331,329 male controls from five cohorts with germline whole exome or genome sequencing data, and one cohort with imputed array data. At the gene level, our case-control collapsing analysis confirms associations between rare damaging variants in four genes and increased prostate cancer risk: <jats:italic>SAMHD1<\/jats:italic>, <jats:italic>BRCA2<\/jats:italic> and <jats:italic>ATM<\/jats:italic> at the study-wide significance level (<jats:italic>P<\/jats:italic>\u2009&lt;\u20091\u00d710<jats:sup>\u22128<\/jats:sup>), and <jats:italic>CHEK2<\/jats:italic> at the suggestive threshold (<jats:italic>P<\/jats:italic>\u2009&lt;\u20092.6\u00d710<jats:sup>\u22126<\/jats:sup>). Our case-only analysis, reveals that rare damaging variants in <jats:italic>AOX1<\/jats:italic> are associated with more aggressive disease (OR\u2009=\u20092.60 [1.75\u20133.83], <jats:italic>P<\/jats:italic>\u2009=\u20091.35\u00d710<jats:sup>\u22126<\/jats:sup>), as well as confirming the role of <jats:italic>BRCA2<\/jats:italic> in determining disease severity. At the single-variant level, our study reveals that a rare missense variant in <jats:italic>TERT<\/jats:italic> is associated with substantially reduced prostate cancer risk (OR\u2009=\u20090.13 [0.07\u20130.25], <jats:italic>P<\/jats:italic>\u2009=\u20094.67\u00d710<jats:sup>\u221210<\/jats:sup>), and confirms rare non-synonymous variants in a further three genes associated with reduced risk (<jats:italic>ANO7<\/jats:italic>, <jats:italic>SPDL1<\/jats:italic>, <jats:italic>AR<\/jats:italic>) and in three with increased risk (<jats:italic>HOXB13<\/jats:italic>, <jats:italic>CHEK2<\/jats:italic>, <jats:italic>BIK<\/jats:italic>). Altogether, this work provides deeper insights into the genetic architecture and biological basis of prostate cancer risk and severity, with potential implications for clinical risk prediction and therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41467-025-56944-1","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:00:58Z","timestamp":1739998858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-4058","authenticated-orcid":false,"given":"Jonathan","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0724-760X","authenticated-orcid":false,"given":"Niedzica","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0722-1311","authenticated-orcid":false,"given":"Konrad H.","family":"Stopsack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-151X","authenticated-orcid":false,"given":"Vijai","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver S.","family":"Burren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8965-0813","authenticated-orcid":false,"given":"Ryan S.","family":"Dhindsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-2428","authenticated-orcid":false,"given":"Jacob E.","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.","family":"Zoghbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-3871","authenticated-orcid":false,"given":"Jesus","family":"Alegre-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0704-9507","authenticated-orcid":false,"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-3317","authenticated-orcid":false,"given":"Jaime","family":"Berumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-2904","authenticated-orcid":false,"given":"Roberto","family":"Tapia-Conyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7792-9422","authenticated-orcid":false,"given":"Jonathan","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-7035","authenticated-orcid":false,"given":"Jason M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-2820","authenticated-orcid":false,"given":"David","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"Matakidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5095-5716","authenticated-orcid":false,"given":"Carolina","family":"Haefliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Anderson-Dring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaidehi","family":"Jobanputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-156X","authenticated-orcid":false,"given":"Keren","family":"Carss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-961X","authenticated-orcid":false,"given":"Slav\u00e9","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Kantoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Offit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorelei A.","family":"Mucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pomerantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7794-610X","authenticated-orcid":false,"given":"Margarete A.","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"56944_CR1","unstructured":"Cancer (IARC), T. I. A. for R. on. Global Cancer Observatory. https:\/\/gco.iarc.fr\/."},{"key":"56944_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"56944_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Primer 7, 9 (2021).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"56944_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. Ca. Cancer J. Clin. 68, 7\u201330 (2018).","journal-title":"Ca. Cancer J. Clin."},{"key":"56944_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/jama.2015.17703","volume":"315","author":"LA Mucci","year":"2016","unstructured":"Mucci, L. A. et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA 315, 68\u201376 (2016).","journal-title":"JAMA"},{"key":"56944_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","volume":"53","author":"DV Conti","year":"2021","unstructured":"Conti, D. V. et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat. Genet. 53, 65\u201375 (2021).","journal-title":"Nat. Genet."},{"key":"56944_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet. 50, 928\u2013936 (2018).","journal-title":"Nat. Genet."},{"key":"56944_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/s41588-023-01534-4","volume":"55","author":"A Wang","year":"2023","unstructured":"Wang, A. et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat. Genet. 55, 2065\u20132074 (2023).","journal-title":"Nat. Genet."},{"key":"56944_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","volume":"577","author":"M Claussnitzer","year":"2020","unstructured":"Claussnitzer, M. et al. A brief history of human disease genetics. Nature 577, 179\u2013189 (2020).","journal-title":"Nature"},{"key":"56944_CR10","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","volume":"382","author":"J de Bono","year":"2020","unstructured":"de Bono, J. et al. Olaparib for metastatic castration-resistant prostate cancer. N. Engl. J. Med. 382, 2091\u20132102 (2020).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen, J. C., Boerwinkle, E., Mosley, T. H. & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264\u20131272 (2006).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1110000","volume":"366","author":"CM Ewing","year":"2012","unstructured":"Ewing, C. M. et al. Germline mutations in HOXB13 and prostate-cancer risk. N. Engl. J. Med. 366, 141\u2013149 (2012).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard, C. C. et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N. Engl. J. Med. 375, 443\u2013453 (2016).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR14","doi-asserted-by":"publisher","unstructured":"Yang, Z. et al. Limited overlap between genetic effects on disease susceptibility and disease survival. medRxiv 2023.10.10.23296544 https:\/\/doi.org\/10.1101\/2023.10.10.23296544 (2023).","DOI":"10.1101\/2023.10.10.23296544"},{"key":"56944_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"56944_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"56944_CR17","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","volume":"586","author":"CV Van Hout","year":"2020","unstructured":"Van Hout, C. V. et al. Exome sequencing and characterization of 49,960 individuals in the UK Biobank. Nature 586, 749\u2013756 (2020).","journal-title":"Nature"},{"key":"56944_CR18","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-023-06595-3","volume":"622","author":"A Ziyatdinov","year":"2023","unstructured":"Ziyatdinov, A. et al. Genotyping, sequencing and analysis of 140,000 adults from Mexico City. Nature 622, 784\u2013793 (2023).","journal-title":"Nature"},{"key":"56944_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/ije\/dyl042","volume":"35","author":"R Tapia-Conyer","year":"2006","unstructured":"Tapia-Conyer, R. et al. Cohort profile: the Mexico City Prospective Study. Int. J. Epidemiol. 35, 243\u2013249 (2006).","journal-title":"Int. J. Epidemiol."},{"key":"56944_CR20","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","volume":"385","author":"100,000 Genomes Project Pilot Investigators.","year":"2021","unstructured":"100,000 Genomes Project Pilot Investigators. et al. 100,000 genomes pilot on rare-disease diagnosis in health care\u2014preliminary report. N. Engl. J. Med. 385, 1868\u20131880 (2021).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41591-023-02682-0","volume":"30","author":"A Sosinsky","year":"2024","unstructured":"Sosinsky, A. et al. Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. Nat. Med. 30, 279\u2013289 (2024).","journal-title":"Nat. Med."},{"key":"56944_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1164\/rccm.201610-2088OC","volume":"196","author":"S Petrovski","year":"2017","unstructured":"Petrovski, S. et al. An exome sequencing study to assess the role of rare genetic variation in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 196, 82\u201393 (2017).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"56944_CR23","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597, 527\u2013532 (2021).","journal-title":"Nature"},{"key":"56944_CR24","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar, S. P. et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat. Genet. 54, 1155\u20131166 (2022).","journal-title":"Nat. Genet."},{"key":"56944_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/rssb.12388","volume":"82","author":"G Wang","year":"2020","unstructured":"Wang, G., Sarkar, A., Carbonetto, P. & Stephens, M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. Ser. B Stat. Methodol. 82, 1273\u20131300 (2020).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"56944_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00329","volume":"6","author":"JE Berchuck","year":"2022","unstructured":"Berchuck, J. E. et al. Addition of germline testing to tumor-only sequencing improves detection of pathogenic germline variants in men with advanced prostate cancer. JCO Precis. Oncol. 6, e2200329 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"56944_CR27","doi-asserted-by":"publisher","unstructured":"Stankovic, S. et al. Genetic links between ovarian ageing, cancer risk and de novo mutation rates. Nature. https:\/\/doi.org\/10.1038\/s41586-024-07931-x (2024).","DOI":"10.1038\/s41586-024-07931-x"},{"key":"56944_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01884-7","author":"OS Burren","year":"2024","unstructured":"Burren, O. S. et al. Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences. Nat. Genet. https:\/\/doi.org\/10.1038\/s41588-024-01884-7 (2024).","journal-title":"Nat. Genet."},{"key":"56944_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41588-021-00944-6","volume":"53","author":"V Codd","year":"2021","unstructured":"Codd, V. et al. Polygenic basis and biomedical consequences of telomere length variation. Nat. Genet. 53, 1425\u20131433 (2021).","journal-title":"Nat. Genet."},{"key":"56944_CR30","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/ije\/dyw179","volume":"45","author":"L Rode","year":"2016","unstructured":"Rode, L., Nordestgaard, B. G. & Bojesen, S. E. Long telomeres and cancer risk among 95\u2009568 individuals from the general population. Int. J. Epidemiol. 45, 1634\u20131643 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"56944_CR31","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1056\/NEJMoa2300503","volume":"388","author":"EA DeBoy","year":"2023","unstructured":"DeBoy, E. A. et al. Familial clonal hematopoiesis in a long telomere syndrome. N. Engl. J. Med. 388, 2422\u20132433 (2023).","journal-title":"N. Engl. J. Med."},{"key":"56944_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-020-00572-y","volume":"44","author":"L Jones","year":"2021","unstructured":"Jones, L., Naidoo, M., Machado, L. R. & Anthony, K. The Duchenne muscular dystrophy gene and cancer. Cell. Oncol. Dordr. 44, 19\u201332 (2021).","journal-title":"Cell. Oncol. Dordr."},{"key":"56944_CR33","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1002\/ijc.31746","volume":"143","author":"E Kaikkonen","year":"2018","unstructured":"Kaikkonen, E. et al. ANO7 is associated with aggressive prostate cancer. Int. J. Cancer 143, 2479\u20132487 (2018).","journal-title":"Int. J. Cancer"},{"key":"56944_CR34","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1091\/mbc.e09-04-0356","volume":"21","author":"M Barisic","year":"2010","unstructured":"Barisic, M. et al. Spindly\/CCDC99 is required for efficient chromosome congression and mitotic checkpoint regulation. Mol. Biol. Cell 21, 1968\u20131981 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"56944_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s42003-021-01910-y","volume":"4","author":"RS Dhindsa","year":"2021","unstructured":"Dhindsa, R. S. et al. Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis. Commun. Biol. 4, 392 (2021).","journal-title":"Commun. Biol."},{"key":"56944_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1183\/09059180.00003613","volume":"22","author":"C Vancheri","year":"2013","unstructured":"Vancheri, C. Common pathways in idiopathic pulmonary fibrosis and cancer. Eur. Respir. Rev. J. Eur. Respir. Soc. 22, 265\u2013272 (2013).","journal-title":"Eur. Respir. Rev. J. Eur. Respir. Soc."},{"key":"56944_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1470-2045(09)70229-3","volume":"10","author":"Y Chen","year":"2009","unstructured":"Chen, Y., Clegg, N. J. & Scher, H. I. Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target. Lancet Oncol. 10, 981\u2013991 (2009).","journal-title":"Lancet Oncol."},{"key":"56944_CR38","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1001\/jamaoncol.2023.3482","volume":"9","author":"BF Darst","year":"2023","unstructured":"Darst, B. F. et al. Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer. JAMA Oncol. 9, 1514\u20131524 (2023).","journal-title":"JAMA Oncol."},{"key":"56944_CR39","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/annonc\/mdv004","volume":"26","author":"Z Kote-Jarai","year":"2015","unstructured":"Kote-Jarai, Z. et al. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes. Ann. Oncol. J. Eur. Soc. Med. Oncol. 26, 756\u2013761 (2015).","journal-title":"Ann. Oncol. J. Eur. Soc. Med. Oncol."},{"key":"56944_CR40","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.eururo.2018.06.021","volume":"74","author":"W Li","year":"2018","unstructured":"Li, W. et al. Genome-wide scan identifies role for AOX1 in prostate cancer survival. Eur. Urol. 74, 710\u2013719 (2018).","journal-title":"Eur. Urol."},{"key":"56944_CR41","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41576-022-00487-4","volume":"23","author":"GL Wojcik","year":"2022","unstructured":"Wojcik, G. L. et al. Opportunities and challenges for the use of common controls in sequencing studies. Nat. Rev. Genet. 23, 665\u2013679 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"56944_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamacardio.2020.6500","volume":"6","author":"G Povysil","year":"2021","unstructured":"Povysil, G. et al. Assessing the role of rare genetic variation in patients with heart failure. JAMA Cardiol. 6, 379\u2013386 (2021).","journal-title":"JAMA Cardiol."},{"key":"56944_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1158\/1078-0432.CCR-24-2483","volume":"31","author":"KH Stopsack","year":"2025","unstructured":"Stopsack, K. H. et al. Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer. Clin. Cancer Res. J. Am. Assoc. Cancer Res. 31, 122\u2013129 (2025).","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"56944_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/ijc.22788","volume":"121","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci, E., Liu, Y., Platz, E. A., Stampfer, M. J. & Willett, W. C. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J. Cancer 121, 1571\u20131578 (2007).","journal-title":"Int. J. Cancer"},{"key":"56944_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3816\/CGC.2006.n.019","volume":"5","author":"WK Oh","year":"2006","unstructured":"Oh, W. K. et al. Development of an integrated prostate cancer research information system. Clin. Genitourin Cancer 5, 61\u201366 (2006).","journal-title":"Clin. Genitourin Cancer"},{"key":"56944_CR46","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"56944_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly 6, 80\u201392 (2012).","journal-title":"Fly"},{"key":"56944_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"56944_CR49","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/ng.3036","volume":"46","author":"A Rimmer","year":"2014","unstructured":"Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. 46, 912\u2013918 (2014).","journal-title":"Nat. Genet."},{"key":"56944_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"56944_CR51","doi-asserted-by":"publisher","first-page":"eadd5430","DOI":"10.1126\/sciadv.add5430","volume":"8","author":"A Nag","year":"2022","unstructured":"Nag, A. et al. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci. Adv. 8, eadd5430 (2022).","journal-title":"Sci. Adv."},{"key":"56944_CR52","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","volume":"26","author":"A Manichaikul","year":"2010","unstructured":"Manichaikul, A. et al. Robust relationship inference in genome-wide association studies. Bioinformatics 26, 2867\u20132873 (2010).","journal-title":"Bioinformatics"},{"key":"56944_CR53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ajhg.2017.01.017","volume":"100","author":"BS Pedersen","year":"2017","unstructured":"Pedersen, B. S. & Quinlan, A. R. Who\u2019s who? Detecting and resolving sample anomalies in human DNA sequencing studies with peddy. Am. J. Hum. Genet. 100, 406\u2013413 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"56944_CR54","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"56944_CR55","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190\u20132191 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56944-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56944-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56944-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:35:02Z","timestamp":1740040502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56944-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56944"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56944-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M., N.C., O.B., R.D., A.N., A.O., A.A., Q.W., L.A.-D., R.M., B.D., K.C., S.P., M.A.F. are current employees and\/or stockholders of AstraZeneca. A.W.Z receives grant funding and consulting fees from AstraZeneca. L.A.M. is on the advisory board and holds equity interest in Convergent Therapeutics. A.M. is a former employee of AstraZeneca and current employee of GSK and a stockholder of AstraZeneca and GSK. C.H. was an employee and stockholder of AZ at the time of study and is a current employee of Debiopharm International. P.W.K. is a co-founder and employee of Convergent Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1779"}}